Hologene 7 (ex-vivo-expanded autologous human keratinocytes containing epidermal stem cells transduced with a COL7-encoding retroviral vector)
/ Holostem
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 16, 2022
HOLOGENE7: Clinical Trial to Assess Safety and Efficacy of Autologous Cultured Epidermal Grafts Containing Epidermal Stem Cells Genetically Modified in Patients With RDEB.
(clinicaltrials.gov)
- P1/2 | N=3 | Terminated | Sponsor: Holostem Terapie Avanzate s.r.l. | Active, not recruiting ➔ Terminated; Replaced by new study in progress
Trial termination
1 to 1
Of
1
Go to page
1